STERIS Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively decreased by 0.4% to $4.34B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.5%, from $4.40B to $4.34B. Over 4 years (FY 2021 to FY 2025), Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively shows an upward trend with a 21.9% CAGR.
Changes are typically driven by stock issuances or share cancellations rather than operational performance.
This represents the par value of the common shares issued and outstanding. It is a fundamental component of shareholders...
Standard accounting line item; usually remains stable unless there is a significant equity financing event.
equity_common_stock_value| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.74B | $4.75B | $4.76B | $4.74B | $4.74B | $4.71B | $4.63B | $4.49B | $4.50B | $4.52B | $4.53B | $4.54B | $4.50B | $4.49B | $4.40B | $4.42B | $4.43B | $4.36B | $4.34B |
| QoQ Change | — | +0.2% | +0.2% | -0.3% | -0.1% | -0.7% | -1.6% | -3.1% | +0.3% | +0.5% | +0.3% | +0.2% | -1.0% | -0.2% | -1.9% | +0.4% | +0.2% | -1.6% | -0.4% |
| YoY Change | — | — | — | — | +0.0% | -0.9% | -2.7% | -5.4% | -5.1% | -4.0% | -2.1% | +1.3% | +0.0% | -0.6% | -2.9% | -2.7% | -1.5% | -2.9% | -1.5% |